Apyx Medical
APYX
72 hedge funds and large institutions have $194M invested in Apyx Medical in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 8 closing their positions.
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
6% more funds holding
Funds holding: 68 → 72 (+4)
6% more capital invested
Capital invested by funds: $183M → $194M (+$10.7M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.5% less ownership
Funds ownership: 55.35% → 54.85% (-0.5%)
35% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$10.2M |
| 2 |
Millennium Management
New York
|
+$1.18M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$832K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$743K |
| 5 |
Morgan Stanley
New York
|
+$523K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$5.69M |
| 2 |
BlackRock
New York
|
-$4.46M |
| 3 |
RC
Roubaix Capital
Denver,
Colorado
|
-$1.75M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$1.29M |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$533K |
APYX Hedge Fund Activity: Q2 2021 in Review
72 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2021, worth a combined $194M — up 5.8% from $183M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new APYX positions and 8 closed out — a net gain of 5 holders — while 17 added to existing stakes and 26 trimmed.
The largest buyer was Cowen and Company, adding an estimated $10.2M. The largest seller was JP Morgan Chase, cutting an estimated $5.69M.
- 72 institutional investors held Apyx Medical (APYX) as of Q2 2021, up from 68 in Q1 2021.
- Funds reported $194M of Apyx Medical stock for Q2 2021, up 5.8% quarter-over-quarter.
- 13 funds opened new Apyx Medical positions in Q2 2021 and 8 closed out, a net change of +5 holders.
- The largest Apyx Medical buyer in Q2 2021 was Cowen and Company, an estimated $10.2M added.
- The largest Apyx Medical seller in Q2 2021 was JP Morgan Chase, an estimated $5.69M sold.
Based on aggregated 13F filings for Q2 2021.